Performance against strategy

To be the cornerstone of healthcare services in South Africa, through the gift of life

Human centered collections

Aspiration

Enhance donor experience through a human centred approach. Enhance brand advocacy.

Strategic Priorities
  • Increase capacity and capability to collect more blood
  • Determine true blood demand
  • Manage deferrals to acceptable levels through strategic initiatives
  • Ensure improved donor outcomes and excellence and deliver excellence in donor care
  • Focus on new donors, youth and black donors
FY2021 Highlights

A looking forward aspect is the success of:

  • #No Stereotypes campaign and its link to diversity and inclusion both in society and in the organisation
  • #IronStrong campaign with a focus on the roll out of iron tablets and ferritin monitoring
Contributing to long-term sustainable value
Related material matters
  • Meeting blood demand
  • Future changing world
  • Covid-19
Creating value for stakeholders Mission Metrics
Improve overall community health Quality & Coverage
Increased collections Coverage
Sufficient blood is the core of our operations and this is how we monitor our collections to deliver on our purpose Coverage
Supply enough platelets to patients Reliability & Coverage
Monitor sustainability of our donor pool Reliability & Quality
Increased black donors – increased collection Reliability & Coverage
Development of SANBS’ visibility and brand enhancement Reliability, Quality & Coverage
Fulfilling our core purpose Reliability, Quality & Coverage

KEY MEASURED INITIATIVES

Target achieved/exceeded
new initiative on track against current plan (no concerns) Target achieved/exceeded Improvement YOY No concerns yet Below target
% Deferrals from all donations
Target IR 2019 IR 2020 Progress April 2020 to March 2021 Outlook for the year ahead 2021/2022 Target
<16.0%
  • 19.72%
  • 14.25%
  • 10.5%
  • Donor optimisation project implemented in 2019/2020 and rolled out in 2020/2021 resulted in a significant impact on number of donors deferred
  • <15%
  • Management of donors with abnormal ferritin levels and increasing iron tablets uptake by donors is a key focus. The inter-donation interval of donors with ferritin levels of 5.0 mcg/L or less will be increased to 3 months to allow iron recovery
  • All donors with ferritin levels below normal cut-off will be advised on measures to improve iron status, including referral to Medical Practitioners where indicated
% Hb Deferrals from all donations - Consolidation of all deferrals
Target IR 2019 IR 2020 Progress April 2020 to March 2021 Outlook for the year ahead 2021/2022 Target
7.5% or less Not measured
  • 7%
  • 5%
  • Year ended with Hb Deferrals at 5% of all donations versus 7% FY2020. The total number of donations against which the Hb Deferrals are measured was 1105830 in FY2019 and 951519 in FY2020
  • The change in the donor pool demographics contributed to the decrease in Hb deferrals (Hb deferral of donors aged 16 to 25 reduced from 10% in FY2019 to 7% in FY2020); this metric was also impacted by the change in Hb cut-off for female donors from 12,5 to 12 g/dL. This change was implemented in combination with the roll-out of ferritin testing to ensure that we protect our donors’ iron stores
  • 7.5% or less
  • Educate donors on the importance of taking Iron tablets issued to them
  • Consolidate the work done under #IronStrong
#Ferritin testing - Roll out in Zones
Target IR 2019 IR 2020 Progress April 2020 to March 2021 Outlook for the year ahead 2021/2022 Target
7 zones Not measured
  • 2
  • Roll-out completion date extended to accommodate resource constraints - completed in May 2021
  • Manage donor Ferritin results
  • Optimise issuing and uptake of iron tablets by donors
No. of source plasma collections
Target IR 2019 IR 2020 Progress April 2020 to March 2021 Outlook for the year ahead 2021/2022 Target
54 121
  • 19 352
  • 40 348
  • 74.6% of target at year end. Collections teams prioritised whole blood and apheresis platelet collections, in view of reduced number of donors. Social distancing practices were implemented, reducing number of donors accommodated. Beds allocated for source plasma collections reduced, in favour of whole blood and apheresis platelet collections
53 848
Days’ cover
Target IR 2019 IR 2020 Progress April 2020 to March 2021 Outlook for the year ahead 2021/2022 Target
4
  • 3.44
  • 5.97
  • 4.6
    4
#Of units of Apheresis platelets collected
Target IR 2019 IR 2020 Progress April 2020 to March 2021 Outlook for the year ahead 2021/2022 Target
16 280
  • 17 072
  • 18 519
  • 18 148
  • Blood products collection targets adjusted to changes in demand, and collections of whole blood and apheresis platelets exceeded these targets by 10.8% and 11.5% respectively
  • 18 510
% First time donors aged 16 – 30 years
Target IR 2019 IR 2020 Progress April 2020 to March 2021 Outlook for the year ahead 2021/2022 Target
70%
  • 69.22%
  • 69.9%
  • 58%
  • High reliance on mobile clinic infrastructure to access blood donors impacted by lockdown level 5, with a 64% cancellation rate. (Incl. blood drives at schools, tertiary institutions, businesses and communities). Higher rates of donor deferral evident among young donors, due to school closures. Easing of restrictions improved access to donors but not to pre-Covid levels; schools operating at 50% capacity
  • >50%
  • Focus on recovering donor base through the Mount Edgecombe strategy. Change in strategy for blood collections, mobile units
Black donors as a percent of total donors
Target IR 2019 IR 2020 Progress April 2020 to March 2021 Outlook for the year ahead 2021/2022 Target
46%
  • 42.55%
  • 46.7%
  • 45%
  • 46%
  • Drive to target communities
Social media engagement
Target IR 2019 IR 2020 Progress April 2020 to March 2021 Outlook for the year ahead 2021/2022 Target
20%
  • 20%
  • 20%
  • 51%
  • Stereotypes Campaign:The #NoStereotypes launch video was one of the top performing posts across all platforms and received over 300,000 combined video views
  • Engagement across all platforms for the duration of the campaign increased significantly
  • 20%
Whole blood collection (Group O)
Target IR 2019 IR 2020 Progress April 2020 to March 2021 Outlook for the year ahead 2021/2022 Target
370 517
  • 413 000
  • 464 942
  • 422 900
  • 473 452

    Navigate to